The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study
Abstract
A 5-week pilot study was conducted to determine if continuous glucose monitoring could be used to improve glycemic control. A total of nine subjects with type 1 diabetes and HbA1c values greater than 8.5% completed the study. Subjects wore a continuous glucose monitor for two 1-week periods during the study. After each sensor use, changes to diet, insulin dosage and self-monitored blood glucose (SMBG) schedule were made. HbA1c decreased from 9.9% (S.D. = 1.1%) at baseline to 8.8% (S.D. = 1.0%) 5 weeks after baseline (P = 0.0006), but daily insulin usage was unchanged over the same period of time (P = 0.428). The glucose sensors performed accurately, with a median correlation of 0.92 and a mean absolute difference of 19.1% (S.D. = 9.0%). The continuous glucose profiles allowed identification of glucose patterns and excursions that helped direct changes in therapy. These treatment changes would not have been made on the basis of meter data alone and were effective in improving glucose control. Additional studies are needed to validate these findings. This pilot study highlights the potential for continuous glucose monitoring to provide the valuable information necessary to make therapy adjustments that can dramatically improve patients' glycemic control and reduce the risk of long-term complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Medtronic Guardian® REAL-Time has been validated against plasma glucose [49] and is widely used in clinical settings [50], [51].”
From Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men (2012) · cites this paper as [51]
In the citing paper
“Standard communication protocols for electronic devices include Bluetooth classic,102 Zigbee,103 and Wi‐Fi.104 However, these protocols have not been designed to be power‐efficient.”
From Wearables in Medicine (2018) · cites this paper as [103]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Hawthorne effect: A reconsideration of the methodological artifact.
Adair, J. G. (1984) · Journal of Applied Psychology · doi:10.1037/0021-9010.69.2.334 · Cited by 1,095 · cited 1×
“These results should be interpreted with caution, due to the lack of a randomized control group in this study, the selection of patients with elevated HbA1c levels, and the potential influence of the Hawthorne effect [5].”
BackgroundClinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 996
The MiniMed Continuous Glucose Monitoring System
Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050214078 · Cited by 394
Self-citationThe Cost to Health Plans of Poor Glycemic Control
Gilmer, T., O’Connor, P. J., Manning, W. G., & Rush, W. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1847 · Cited by 303
Cited by
Sorted by citations
Items 201–231 of 231
Joseph, J. I. (2016) · doi:10.3109/9780849379581-41 · Cited by 1
Betônico, C. D. C. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-05042017-153224 · Cited by 1
Crossing boundaries : patients' experiences of using a diabetes eHealth system
Gregory, P. (2012) · CLOK (University of Central Lancashire) · Cited by 1
Technology and Diabetes: Insulin Delivery Systems and Glucose Sensing
Bode, B. W. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_17
Self-citationChanging Physical Activity Behavior with Continuous Glucose Monitoring: A Dissertation
Allen, N. A. (2006) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/z61a-vw08 · Cited by 1
Hod, M., & Yogev, Y. (2005) · KARGER eBooks · doi:10.1159/000087424
Insulin Therapy and Outpatient Diabetes Management
KAUFMAN, F. R. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0507-5_11
Artificial and Bio‐artificial Pancreas Systems
Reach, G., Dulong, J., & Legallais, C. (2003) · doi:10.1002/0470862092.d0703
Renard, É. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70148-6
Self-monitoring of blood glucose—problems with progress
Pirie, F. J. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872196
Wohlfarth, K. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15179
Le CGMS TM : un système de mesure glycémique en continu
Renard, É. (2006) · Sang thrombose vaisseaux
Chirino, E. C., Pérez, M. D. L. C. R., Martínez, A. I. M., Busquet, S. V., & Rodríguez, F. M. (2011) · Revista Habanera de Ciencias Médicas
Kerssen, A. (2005) · Utrecht University Repository (Utrecht University)
Point-of-Care Testing in the Management of Diabetes Mellitus
Winter, W. E. (2002) · CRC Press eBooks · doi:10.1201/b14092-11
Interactions between therapeutic protein formulations and surfaces
Teska, B. M. (2015) · doi:10.25677/a1gd-5c31
Chapter 4 Continuous glucose monitoring systems
Vashist, S. K., & Luong, J. H. T. (2016) · CRC Press eBooks · doi:10.1201/9781315366746-5
Robinson-Vincent, K. A. (2015) · TSpace (University of Toronto)
Davey, R. J. (2010) · UWA Profiles and Research Repository (UWA)
Das, S. (2016) · Nursing & Care Open Access Journal · doi:10.15406/ncoaj.2016.01.00011
Algorithm for offline recalibration of recorded CGM traces
Reiterer, F., Zeindl, H. P., & del Re, L. (2018) · Middle East Conference on Biomedical Engineering · doi:10.1109/mecbme.2018.8402439
Wentholt, I. M. E., Maran, A., & Masurel, N. (2007)
Sandoval-Palomares, J. D. J., & Yáñez-Mendiola, J. (2019) · International Journal of Biosensors & Bioelectronics · doi:10.15406/ijbsbe.2019.05.00167
Uduku, C. N., Reddy, M., & Oliver, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00007-7
MBBS, M. G. M., & Sekhar, D. M. S. (2020) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v8i11.30
Jc, S., & Rao, P. V. (2021) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/6100257
Rahaghi, F. N., & Gough, D. A. (2006) · Encyclopedia of Medical Devices and Instrumentation · doi:10.1002/0471732877.emd124
Joseph, J. I. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-39
Blood Glucose Monitoring and Glycemic Control
Reineke, E. L. (2023) · doi:10.1002/9781119581154.ch73
Peripheral Hypoglycaemic Neuropathy in Type 1 Diabetic Rats : Morphologic and Metabolic Studies
Jamali, R. (2006) · DiVA (Linkoping University)
Assessing Glycaemic Control in Cystic Fibrosis
Helm, J. (2011) · Research Explorer (The University of Manchester)
Metadata
- Authors
- Bode, B. W., Gross, T. M., Thornton, K. R., & Mastrototaro, J. J.
- Affiliations
- Atlanta Diabetes Associates (US)
- Corresponding author
- Bode, Bruce W.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 46
- Issue
- 3
- Pages
- 183-190
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2103516801
- Cited by
- 232
- References
- 5
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 9 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, glycemic control, HbA1c, insulin dose adjustment, self-monitoring of blood glucose
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin, Male, Middle Aged, Monitoring, Physiologic, Pilot Projects, Therapy, Computer-Assisted, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
